Quarterly report pursuant to Section 13 or 15(d)

Condensed Interim Statements of Cash Flows

v2.4.0.6
Condensed Interim Statements of Cash Flows (USD $)
 8 Months Ended 9 Months Ended 20 Months Ended
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2012
Cash Flows from Operating Activities:      
Net loss $ (485,274) $ (976,910) $ (1,758,229)
Adjustments to reconcile net loss to net cash used in operating activities:      
Prepaid insurance (52,456) 31,713 0
Accrued expenses and accounts payable 0 289,120 362,687
Franchise tax payable 68,220 135,000 248,222
Net cash used in operating activities (469,510) (521,077) (1,147,320)
Cash Flows from Investing Activities:      
Principal deposited in Trust Account (189,626,500) 0 (189,626,500)
Interest reinvested into Trust Account (5,389) (7,897) (15,937)
Net cash used in investing activities (189,631,889) (7,897) (189,642,437)
Cash Flows from Financing Activities:      
Proceeds from sale of common stock to Sponsor 25,000 0 25,000
Proceeds from note payable to Sponsor 140,000 250,000 390,000
Net proceeds from Public Offering, after payment of upfront underwriting fee 186,126,500 0 186,126,500
Net proceeds from private placement 5,250,000 0 5,250,000
Repayment of Sponsor note (140,000) 0 (140,000)
Payment of offering expenses (694,436) 0 (694,436)
Net cash provided by financing activities 190,707,064 250,000 190,957,064
Increase (decrease) in cash during period 605,665 (278,974) 167,307
Cash at beginning of period 0 446,281 0
Cash at end of period 605,665 167,307 167,307
Supplemental Disclosure of Non-Cash Financing Activities:      
Deferred underwriting compensation $ 6,647,375 $ 0 $ 6,647,375